The biotechnologist Daniel Ramón has joined as full member the Royal Academy of Engineering during a ceremony hold on the 21 January 2020, after this scientific institution decided so last April on the motion of the Academics Avelino Corma, Elías Fereres and Enrique Cerdá.

Daniel Ramón, currently Vice President of R&D for Nutrition & Health at ADM, is one of the founders of the biotechnological company Biopolis, born in 2003 as a spin-off from the Spanish Research Council (CSIC) and placed in the Science Park of the Universitat de València since 2008. Founded with the main goal of transferring quality science to the agrifood, chemical and pharmaceutical industries, the company was acquired about three years ago by the American multinational Archer Daniels Midland (ADM), one of the largest farm processors and food ingredients suppliers in the world, becoming ADM-Biopolis in its Valencian subsidiary.

ADM Biopolis has a scientific collaboration agreement with the Institute for Integrative Systems Biology (I2SysBio), a joint centre of the Universitat de València and CSIC, to develop strategic research projects of common interest in the field of synthetic and systems biology.

As member of I2SysBio, Daniel Ramón is part of the Metabolic Systems Engineering Research Group. He has been a Research Professor at the Spanish Research Council, at the Institute of Agrochemistry and Food Technology (IATA), and Professor of Food Technology at the Universitat de València.

Ramón’s technological results are protected by more than forty national and international patents, the most of which are transferred and in use. His research career has been awarded with the prize of the Spanish Society for Microbiology, the prize for his Scientific career of Instituto Danone, the Juan de la Cierva National Research Award, the International Hippocrates Award, the Medal of Promotion of the Invention of García Cabrerizo Foundation, and the Award Nutrachampion which is annually given to one of the most influential people in the sector by the nutraceutical industry.

He is member of the Scientific Committee of “Microbial Resource Research Infrastructure”, of the “Board of Directors” of the “Pharmabiotec Research Institute”, of the Rector Council of the Spanish Research Council and of the Board of Directors of the management of biotechnological companies ASEBIO, among others.